ZOLOFT 25 MG
SERTRALINE (SERTRALINE HYDROCHLORIDE) : 25 MG · DIN 02132702 · BGP PHARMA ULC
Health Canada status: MARKETED
What is ZOLOFT?
ZOLOFT 25 MG contains SERTRALINE (SERTRALINE HYDROCHLORIDE) : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 02132702, held by BGP PHARMA ULC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 22-Aug-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ZOLOFT used for?
Symptomatic relief of depressive illness, panic disorder (with or without agoraphobia), and obsessive-compulsive disorder (OCD) in adults.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is ZOLOFT called?
The same molecule, SERTRALINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| APO-Sertraline | Latin | Australia |
| Blooms The Chemist Sertraline | Latin | Australia |
| Sertraline generichealth | Latin | Australia |
| Sertraline Sandoz | Latin | Australia |
| SERTRALINE-WGR | Latin | Australia |
| SERTRALINE GT | Latin | Morocco |
| Setrona | Latin | Australia |
| Lustalin | Latin | Saudi Arabia |
| NO-DEP | Latin | Morocco |
| DEPRESTAT | Latin | Morocco |
| Sertidep | Latin | Saudi Arabia |
| Setral | Latin | Saudi Arabia |
| PSYTRAL | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02132702 |
|---|---|
| Brand name | ZOLOFT |
| Generic / active ingredient | SERTRALINE (SERTRALINE HYDROCHLORIDE) : 25 MG |
| Manufacturer | BGP PHARMA ULC |
| Strength | 25 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AB06 SERTRALINE |
| AHFS class | 28:16.04.20 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 22-Aug-2023 |
| Original market date | 1995-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02132702 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2132702 |
| Brand name | ZOLOFT |
| Active ingredient / INN | SERTRALINE (SERTRALINE HYDROCHLORIDE) : 25 MG |
| ATC code | N06AB06 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N06 |
| AHFS class | 28:16.04.20 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | BGP PHARMA ULC |
How is it administered?
Initial: 50 mg/day for depression/OCD; 25 mg/day for panic disorder (increase to 50 mg after 1 week). Max: 200 mg/day. Administer once daily with food (morning or evening).
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly stated in the provided text (section 11 refers to a page not fully detailed), though standard pharmaceutical storage is implied.
How is it supplied?
White high density polyethylene bottles of 100 capsules (all strengths) and 250 capsules (50 mg strength).
Which pack is which?
| Strength on the label | 25 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
| Packaging as described in the monograph | White high density polyethylene bottles of 100 capsules (all strengths) and 250 capsules (50 mg strength). |
| Storage | Not explicitly stated in the provided text (section 11 refers to a page not fully detailed), though standard pharmaceutical storage is implied. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Contraindications
Hypersensitivity to sertraline or any ingredient; concomitant use with MAOIs (within 14 days); concomitant use with pimozide due to risk of QT prolongation and arrhythmias.
Warnings and precautions
Increased risk of self-harm and suicidal thinking. Risk of QTc prolongation, Torsade de Pointes, Serotonin Syndrome, abnormal bleeding, hyponatremia, and discontinuation symptoms.
Is SERTRALINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N06AB06 SERTRALINE. 54 of 105 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-SERTRALINE | 100 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02477904 |
| AG-SERTRALINE | 25 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02477882 |
| AG-SERTRALINE | 50 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02477890 |
| APO-SERTRALINE | 100 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02238282 |
| APO-SERTRALINE | 25 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02238280 |
| APO-SERTRALINE | 50 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02238281 |
| AURO-SERTRALINE | 100 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02390922 |
| AURO-SERTRALINE | 25 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02390906 |
| AURO-SERTRALINE | 50 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02390914 |
| BIO-SERTRALINE | 100 MG | CAPSULE | BIOMED PHARMA | MARKETED | DIN 02445069 |
Who else supplies SERTRALINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SERTRALINE appears in 4790 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does SERTRALINE cost around the world?
SERTRALINE is listed on 7 national price registers Nexara tracks, across 290 pack listings published on 7 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 6 | 140 | 03 Sep 2026 |
| Australia | ex-manufacturer | 11 | 68 | 08 Sep 2026 |
| Greece | producer price (ex-factory) | 24 | 24 | 03 Sep 2026 |
| South Africa | single exit price | 21 | 21 | 01 Sep 2026 |
| Morocco | PPV (public price) | 6 | 17 | 05 Sep 2026 |
| Saudi Arabia | public | 10 | 17 | 01 Sep 2026 |
| United Kingdom | hospital | 3 | 3 | 31 Aug 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.